GlucoSet: Funding, Investors & Team (Oct 2026)
GlucoSet is a company in the medical field that is focused on creating advanced sensor technology to enhance glucose management in intensive care units. In ICU patients, blood sugar levels are often high and fluctuating, which can result in expensive infections, prolonged hospital stays, and even death. The GlucoSet intravascular sensor offers a continuous and precise measurement of a patient's blood glucose level, allowing for the regulation of glucose levels without the danger of sudden and excessively low levels.
GlucoSet has raised $6.6M across 1 funding round on record, the most recent a Series A of $6.6M announced in Jul 2023.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
GlucoSet Company Profile and Key Stats
Latest funding round on record: Jul 2023.
GlucoSet Funding Rounds
GlucoSet Founders and Leadership Team
No contact details are on record for this team yet.
GlucoSet Funding Compared to Other Health Care Startups
GlucoSet's latest round of $6.6M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GlucoSet in Health Care and Trondhjem
Companies Similar to GlucoSet
Stready is supercharging loyalty by enabling e-tailers to leverage workout data.
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and…
CureMeAbroad operates as an AI-powered medical tourism concierge, matching patients from Western markets.
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
GlucoSet Funding FAQs
What does GlucoSet do?
GlucoSet is a company in the medical field that is focused on creating advanced sensor technology to enhance glucose management in intensive care units. In ICU patients, blood sugar levels are often high and fluctuating, which can result in expensive infections, prolonged hospital stays, and even death. The GlucoSet intravascular sensor offers a continuous and precise measurement of a patient's blood glucose level, allowing for the regulation of glucose levels without the danger of sudden and excessively low levels.
How much funding has GlucoSet raised?
GlucoSet has raised $6.6M across 1 round on record. The most recent is a Series A of $6.6M announced in Jul 2023.
When did GlucoSet last raise funding?
GlucoSet's most recent funding round on record is a Series A of $6.6M, announced in Jul 2023.
Who founded GlucoSet?
FundedIQ lists Dag Roar Hjelme (Founder) at GlucoSet.
Where is GlucoSet headquartered?
GlucoSet is based in Trondhjem, Sor-Trondelag, Norway.
How many employees does GlucoSet have?
GlucoSet is in the 11-50 employee band.
How does GlucoSet's funding compare to other Health Care startups?
GlucoSet's latest round of $6.6M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's GlucoSet Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GlucoSet is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.